GB2442164B - Treatment of neurodegenerative conditions - Google Patents

Treatment of neurodegenerative conditions

Info

Publication number
GB2442164B
GB2442164B GB0725392A GB0725392A GB2442164B GB 2442164 B GB2442164 B GB 2442164B GB 0725392 A GB0725392 A GB 0725392A GB 0725392 A GB0725392 A GB 0725392A GB 2442164 B GB2442164 B GB 2442164B
Authority
GB
United Kingdom
Prior art keywords
treatment
neurodegenerative conditions
neurodegenerative
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0725392A
Other versions
GB2442164A (en
GB0725392D0 (en
Inventor
Michael J Leach
Laurence S Harbige
Mohammed Sharief
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0319358A external-priority patent/GB0319358D0/en
Priority claimed from GB0410846A external-priority patent/GB0410846D0/en
Application filed by BTG International Ltd filed Critical BTG International Ltd
Priority to GB0725392A priority Critical patent/GB2442164B/en
Priority claimed from GB0603646A external-priority patent/GB2422373B/en
Publication of GB0725392D0 publication Critical patent/GB0725392D0/en
Publication of GB2442164A publication Critical patent/GB2442164A/en
Application granted granted Critical
Publication of GB2442164B publication Critical patent/GB2442164B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
GB0725392A 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions Expired - Fee Related GB2442164B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0725392A GB2442164B (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0319358A GB0319358D0 (en) 2003-08-18 2003-08-18 Treatment of neurodegenerative conditions
GB0410846A GB0410846D0 (en) 2004-05-14 2004-05-14 Treatment of neurodegenerative conditions
GB0725392A GB2442164B (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
GB0603646A GB2422373B (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions

Publications (3)

Publication Number Publication Date
GB0725392D0 GB0725392D0 (en) 2008-02-06
GB2442164A GB2442164A (en) 2008-03-26
GB2442164B true GB2442164B (en) 2008-05-21

Family

ID=39126168

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0725392A Expired - Fee Related GB2442164B (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions

Country Status (1)

Country Link
GB (1) GB2442164B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
WO2001097793A2 (en) * 2000-06-23 2001-12-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
WO2003013497A1 (en) * 2001-08-02 2003-02-20 Suntory Limited Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
GB2415378A (en) * 2003-05-14 2005-12-28 Btg Int Ltd Use of triglyceride oils containing gamma-linolenic acid residues and linolenic acid residues for the treatment of neurogenerative disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
WO2001097793A2 (en) * 2000-06-23 2001-12-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
WO2003013497A1 (en) * 2001-08-02 2003-02-20 Suntory Limited Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
GB2415378A (en) * 2003-05-14 2005-12-28 Btg Int Ltd Use of triglyceride oils containing gamma-linolenic acid residues and linolenic acid residues for the treatment of neurogenerative disease

Also Published As

Publication number Publication date
GB2442164A (en) 2008-03-26
GB0725392D0 (en) 2008-02-06

Similar Documents

Publication Publication Date Title
GB2415378B (en) Treatment of neurodegenerative conditions
GB2422373B (en) Treatment of neurodegenerative conditions
EG24420A (en) Treatment of ophthalmic conditions
EP1635763A4 (en) Method of treating neurodegenerative disease
EP1689485A4 (en) Cardioelectromagnetic treatment
IL175535A0 (en) Compositions for treatment of neurodegenerative diseases
EP1617844A4 (en) Treatment of neurological conditions
EP1654260A4 (en) 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders
GB0326486D0 (en) Combination treatment
EP1658072A4 (en) Compounds for the treatment of neurodegenerative disorders
GB0312407D0 (en) Treatment
EP1653982A4 (en) Treatment of malodour
GB0300783D0 (en) Treatment of neurodegenerative conditions
AU2003259833A8 (en) Methods of treating neurodegenerative diseases
GB0306309D0 (en) Method of treatment
GB0302572D0 (en) Method of treatment
EP1691776A4 (en) Treatment of aids
GB0329416D0 (en) Treatment of cancer
GB2422600B (en) Sludge treatment
GB2442164B (en) Treatment of neurodegenerative conditions
GB0319358D0 (en) Treatment of neurodegenerative conditions
GB0724618D0 (en) Treatment of neurodegenerative conditions
GB0327975D0 (en) Methods of treatment
GB0325838D0 (en) Wastewater treatment
GB0410846D0 (en) Treatment of neurodegenerative conditions

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20120927 AND 20121003

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20220813